Search

Board

The EHA Board is the governing body of the association and deals with issues of policy. The Board sets the goals and objectives of the association in conformity with the EHA's statutes. Current members of EHA's Executive Board

Read more

Regulation on Health Technology Assessment

The Regulation on Health Technology Assessment (HTAR) was proposed by the European Commission in 2018. It was formally adopted in December 2021 and will apply from January 2025.

Read more

Congress platform

The EHA2024 Hybrid Congress content is entirely accessible on the Congress platform.  

Access the EHA2024 Congress platform 

To access the Congress platform, please use your credentials.

Read more

Registration

Register here

Individual registrationHybrid registration includes:

In-person access to the scientific and educational sessions of the meeting
Access to the virtual platform
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8,2025
Access to the Welcome Reception
Access to the Poster Session(s) and viewing…

Read more

EHA-BMSH Balkan Hematology Tutorial

EHA is joining the Bulgarian Medical Society of Hematology (BMSH) to organize the EHA-BMSH Balkan Hematology Tutorial on Myeloproliferative Neoplasms.

Read more

I would like to be an EHA Guest

Would you like to connect with EHA, but you do not feel ready to fully commit yet? By becoming an EHA Guest, you will enjoy:

Free access to the European Hematology Curriculum
Limited access the EHA Campus
Receive EHA Newsflashes to keep you informed…

Read more

Sponsor Opportunities

The European Hematology Association (EHA) invites you to support the 7th European CAR T-cell Meeting.

Read more

Registration & Accommodation

Register Now

Registration fee includes:

Access to the scientific and educational sessions of the meeting
Networking opportunities during breaks and welcome reception
Catering during meeting hours incl.

Read more

About us

The European Hematology Association (EHA): “Towards prevention, cure, and quality of life for all patients with blood disorders”.

Read more